骨质疏松可能并非无骨水泥全膝关节置换术的绝对禁忌证
本研究基于2010至2022年全国行政理赔数据库回顾性分析≤75岁骨质疏松患者行初次全膝关节置换术,倾向性评分匹配后比较无骨水泥与骨水泥组(1,321例 vs 6,602例),发现两组植入物相关并发症、医疗并发症、再入院率及3年假体生存率均无统计学显著差异。作者认为无骨水泥全膝关节置换术对<75岁骨质疏松患者是可行选择,但术中仍需根据骨质量决定是否适用。
要点
- 骨质疏松患者无骨水泥与骨水泥全膝关节置换术后并发症及再入院率无显著差异。
- 3年假体生存率骨水泥组97.6% vs 无骨水泥组97.2%,无统计学显著差异(P=0.472)。
- 作者认为无骨水泥技术对<75岁骨质疏松患者是可行选择,但术中仍需评估骨质量。
核心结论
- 骨质疏松患者行无骨水泥全膝关节置换术的医疗并发症、植入物相关并发症及3年假体生存率与骨水泥技术相当。
- 作者认为结果支持无骨水泥全膝关节置换术作为<75岁患者的可行选择,无论既往是否诊断骨质疏松。
- 术中仍需根据骨质量决定患者是否适合无骨水泥全膝关节置换术。
研究设计与样本
- 回顾性队列研究,证据等级III级。
- 查询2010至2022年全国行政理赔数据库,纳入≤75岁骨质疏松行初次全膝关节置换术患者。
- 按年龄、性别、肥胖及Charlson共病指数进行倾向性评分匹配,匹配后共7,923例(无骨水泥1,321例,骨水泥6,602例)。
- 采用多因素logistic回归评估90天和2年植入物相关并发症、90天术后医疗并发症及90天再入院;Kaplan-Meier分析评估3年全因翻修假体生存率。
- 显著性阈值设为P<0.01以减少1型偏倚。
主要发现
- 无骨水泥与骨水泥全膝关节置换术组在植入物相关并发症、医疗并发症、再入院率及住院时长方面均无统计学显著差异。
- Kaplan-Meier分析显示两组3年假体生存率统计学相似:骨水泥组97.6%(置信区间96.6至98.5)vs 无骨水泥组97.2%(置信区间96.7至97.7),P=0.472。
临床怎么用
- 作者认为无骨水泥全膝关节置换术可作为<75岁骨质疏松患者的可行选择,无论既往是否诊断骨质疏松。
- 作者指出术中仍需根据骨质量判断患者是否适合无骨水泥全膝关节置换术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cementless total knee arthroplasty (TKA) has received growing interest, particularly in younger populations, due to potential long-term survivability and improved bone preservation. Poor bone stock, as seen in osteoporosis, is considered a contraindication for this technique. This study evaluated whether osteoporotic patients < 75 years undergoing cementless TKA demonstrate similar: 1) implant-related complications, 2) medical complications, 3) readmission rates, and 4) 3-year implant survivability. METHODS: A retrospective query of a national administrative claims database was performed between 2010 and 2022 for patients less than or equal to 75 years old who have osteoporosis and underwent primary TKA. Osteoporotic patients were divided into cementless and cemented cohorts, and propensity scores were matched based on age, sex, obesity, and the Charlson Comorbidity Index. Matching produced 7,923 patients (1,321 uncemented, 6,602 cemented). Multivariate logistic regressions evaluated the following outcomes: 90-day and 2-year implant-related complications, 90-day postoperative medical complications, and 90-day readmissions. Kaplan-Meier survival analysis was conducted to assess 3-year all-cause revision implant survivability. The significance threshold was set to P < 0.01 to minimize type 1 bias. RESULTS: There were no statistically significant differences in implant-related complications, medical complications, readmissions, and lengths of stay between cementless and cemented TKA groups. Kaplan-Meier analysis demonstrated statistically similar 3-year survivability between cohorts (cemented: 97.6%, confidence interval 96.6 to 98.5; cementless: 97.2%, confidence interval 96.7 to 97.7; P = 0.472). CONCLUSIONS: Patients who have osteoporosis have equivalent medical and implant-related complications as well as 3-year implant survival following cementless TKA compared with a cemented technique. Our results support cementless TKA as a viable option for patients < 75 years, regardless of prior diagnosis of osteoporosis. Intraoperative decisions regarding bone quality are still necessary to discriminate between those who are candidates for cementless TKA with those who are not. LEVEL OF EVIDENCE: Level III, Retrospective cohort study.
引用
- Xu JJ, Magruder ML, Lama G, et al. Osteoporosis May Not Be an Absolute Contraindication for Cementless Total Knee Arthroplasty. J Arthroplasty. 2024. PMID: 39419420. doi:10.1016/j.arth.2024.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。